Sero-epidemiological Survey of England in 2019/2020 - COVID-19

CompletedOBSERVATIONAL
Enrollment

2,963

Participants

Timeline

Start Date

October 15, 2019

Primary Completion Date

June 30, 2021

Study Completion Date

June 14, 2022

Conditions
Serogroup C Meningococcal MeningitisDiphtheriaCOVID-19
Interventions
PROCEDURE

Venepuncture

"One study visit will be conducted by research study staff and blood sampling will be carried out.~Up to three follow-up visits will be conducted for a percentage of participants, where additional blood samples will be collected. The blood sample will initially focus on looking at population immunity to diphtheria, group C invasive meningococcal disease and SARS-CoV-2."

PROCEDURE

Oral fluid swab

Saliva sampling will be collected during the follow-up visits. This swab will be collected either by the participant or the participants parent/guardian on the day of the visit. The saliva sampling will primarily be analysed for SARS-CoV-2 antibodies.

Trial Locations (1)

OX3 7LE

Centre for Clinical Vaccinology & Tropical Medicine (CCVTM), Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT04061382 - Sero-epidemiological Survey of England in 2019/2020 - COVID-19 | Biotech Hunter | Biotech Hunter